Teaming up: feasibility of an online treatment environment for adolescents with type 1 diabetes

Pediatric Diabetes
Emiel A BoogerdChris M Verhaak

Abstract

To evaluate the feasibility of an online interactive treatment environment for adolescents with type 1 diabetes, called Sugarsquare, to supplement usual care. Sugarsquare provides easily accessible contact with the diabetes team, peer support, and treatment overview. Of 120 eligible patients, 62 adolescents aged 11-21 (M = 15.23, SD = 2.00) were assigned to a usual-care group (n = 31) or a usual-care + intervention group (n = 31). Feasibility was assessed in terms of acceptability, demand, practicability, integration, and efficacy in a 9-month study-period. Assessment of acceptability and demand revealed that 20 adolescents in the intervention group (65%) logged in at least once; 16 adolescents (52%) logged in repeatedly. Usage resulted in 5795 page-views, 3580 chat-messages, 427 forum-messages, and in 40 private interactions between 11 adolescents (35%) and professionals. Assessment of practicability revealed that all 13 professionals (100%) accessed the intervention. Slow processing speed and security procedures formed obstacles for usage. Assessment of integration showed that international standards for diabetes care (International Diabetes Federation/International Society for Pediatric and Adolescent Diabetes/American Diabe...Continue Reading

References

May 20, 1998·Diabetes Care·J T FitzgeraldW K Davis
Mar 10, 2001·Social Science & Medicine·K Tates, L Meeuwesen
Aug 29, 2003·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Bryony A Beresford, Patricia Sloper
Oct 28, 2004·Nursing & Health Sciences·Helvi Kyngäs
Jan 29, 2005·Clinical Pediatrics·Eric A Storch, Deborah Roth Ledley
Jul 23, 2005·Journal of Telemedicine and Telecare·Pam LoweFrances Griffiths
Oct 18, 2005·The Medical Journal of Australia·Susan M Sawyer, Rosalie A Aroni
Sep 20, 2006·Human Reproduction·W S TuilJ A M Kremer
Jan 29, 2008·Qualitative Health Research·Vibeke ZoffmannMarit Kirkevold
Feb 20, 2008·Annals of Internal Medicine·Isabelle BoutronUNKNOWN CONSORT Group
Apr 14, 2009·American Journal of Preventive Medicine·Deborah J BowenMaria Fernandez
Apr 24, 2009·Journal of Clinical Psychology in Medical Settings·Heather D LehmkuhlGary R Geffken
May 1, 2009·Journal of Medical Internet Research·Cecilia NordqvistSam Nordfeldt
May 26, 2009·The Journal of Pediatrics·Roberto IzquierdoRuth S Weinstock
Sep 17, 2009·Pediatric Diabetes·Peter G F Swift
Sep 17, 2009·Pediatric Diabetes·Alan M Delamater
Mar 17, 2011·Diabetes Technology & Therapeutics·Dario IafuscoAndrea Scaramuzza
Aug 9, 2011·Journal of Medical Internet Research·Liesje DonkinNick Glozier
Dec 6, 2011·Journal of Pediatric Psychology·Victoria A Miller, Diana Harris
Jan 4, 2012·Diabetes Care·UNKNOWN American Diabetes Association
Mar 27, 2012·Diabetes, Obesity & Metabolism·M A HarrisS A Mulvaney
Mar 31, 2012·Journal of Pediatric Psychology·Dianne K Palladino, Vicki S Helgeson
Oct 20, 2012·Social Work in Health Care·David B NicholasDenis Daneman
Oct 30, 2012·Journal of Medical Internet Research·Elvira M E den BreejenJan A M Kremer
Apr 13, 2013·Diabetes Care·Margaret GreyUNKNOWN TeenCope Study Group
May 1, 2013·Pediatric Diabetes·Donna S Eng, Joyce M Lee
May 1, 2013·Pediatric Diabetes·F J CameronUNKNOWN Hvidoere International Study Group

❮ Previous
Next ❯

Citations

Dec 15, 2016·Pilot and Feasibility Studies·Sandra M EldridgeUNKNOWN PAFS consensus group
Jun 19, 2015·Current Opinion in Endocrinology, Diabetes, and Obesity·Jennifer Raymond
Jul 30, 2019·Indian Journal of Pediatrics·Binay Kumar PramanikAnna Simon
Feb 6, 2017·Journal of the American Medical Informatics Association : JAMIA·Selena DavisLee MacKay
Apr 20, 2018·Diabetes Technology & Therapeutics·Mark W ReidJennifer K Raymond

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.